The EPS projection of Procter & Gamble Co (NYSE:PG) for quarter ended 2016-09-30 is $1. Last week, the projection for EPS was $1 against target of $1, a month earlier. While 2-months ago, this projection was $1 versus forecast of $1a quarter months earlier, posting a deviation of 0%.
Procter & Gamble Co (NYSE:PG) posted that 18 days earlier, the share price was revised 0 times on upside. In addition, negative revisions were 3.
In last week, negative EPS revisions were 0 times and positive EPS revisions were 0 times. In last one-month and two month the positive revisions were 0 and 0. While in last 120 and 90 days, positive revisions were 0, and 0, correspondingly.
The per-share earnings downgrade for Procter & Gamble Co (NYSE:PG) in the preceding 30 and 120 were 0 and 4. While in 60 and 90 days were 0, and 4, in that order.
Procter & Gamble Co (NYSE:PG) EPS target was $1 for the quarter closed 3. It was based on 10 calls. As on 2016-04-26 the EPS was $0.86. The change was $0.05, posting a deviation of 6.17%. The price projections gave a standard deviation of 0.02.
Quarterly Sales Estimates
Procter & Gamble Co (NYSE:PG) sales prediction for the fiscal 2017 stands at $16241.525 and the median estimate is at $16245.05. Almost 4 analysts gave sales target.
Among this, the highest sales estimate is $16381 while the lowest target is $16095 showing standard deviation of 153.029%.
As many as 4 analysts have positive sales targets revision while 4 reduced sales estimates, posting a deviation of 0%.
Last month, 4 experts have positive sales number revision. Also, 4 research groups lowered the sales projections, posting a deviation of 0%.
A quarter ago, 4 hiked sales target and 4 reduced sales forecast, posting a deviation of 0.619%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...